Especially uplist tbh, it seems like AMFE has exhausted the capital OTC pink has to offer. Oh well, it is what it is, hopefully uplist to QB will take us to .3+ range
Be careful what you ask for. It's great AMFE's Audit is out but the Audit confirmed the lack of AMFE's Net Profits and Increasing Debt. This may be one reason there is no Buying Pressure. AMFE's PPS may move under .10 by Friday.